-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Novartis Temporarily Pausing Screening, Randomization And Treatment Across Rapcabtagene Autoleucel Trials In Autoimmune Diseases

Reuters·09/01/2026 07:26:32

Please log in to view news